U.S. Biotech Stock News

Tilray Brands (TLRY) just posted Q2 2026 results with revenue of US$217.5 million, a basic EPS loss of US$0.41, and net income loss of US$44.9 million, putting the focus squarely on how the income statement is evolving through the year. The company has seen quarterly revenue move between US$200.0 million and US$224.5 million over the past six reported periods, while basic EPS has ranged from a small loss of roughly US$0.00 to much larger quarterly losses in 2025 and 2026. This keeps attention...

CAVA Group (CAVA) just rolled out its biggest menu expansion yet, bringing back white sweet potatoes and adding several Mediterranean themed items, a move that has caught the attention of both guests and investors. See our latest analysis for CAVA Group. The menu launch and recent analyst commentary have coincided with strong short term momentum, with a 30 day share price return of 33.47% and a year to date share price return of 17.03%, even though the 1 year total shareholder return is a...

Why SFL (SFL) is Back on Income Investors’ Radar Fearnley Securities recently picked SFL bonds as among its preferred ideas, pointing to the company’s diversified exposure and contract backlog. At the same time, equity investors are reexamining SFL stock as a steady dividend and cash flow play. See our latest analysis for SFL. SFL’s share price has climbed 19.81% over the past 90 days and 5.39% year to date, yet its 1 year total shareholder return of 13.93% decline shows recent momentum...

Zacks recently upgraded Credicorp to a Rank #1 (Strong Buy) after analysts raised their earnings estimates, signaling improved sentiment toward the group’s underlying business outlook. This shift in analyst expectations highlights how Credicorp’s evolving earnings profile is increasingly central to how market participants assess its long‑term potential. We’ll now examine how the Zacks Rank upgrade and stronger earnings forecasts could reshape Credicorp’s investment narrative and risk...

If you are wondering whether Brighthouse Financial at around US$64.70 is still offering value or starting to look fully priced, you are not alone. The stock has returned 0.2% over the last week, a 1.2% decline over the past month, 0.2% year to date and 41.5% over the last year, with longer term returns of 19.8% over three years and 53.4% over five years. Recent coverage has focused on Brighthouse Financial as a listed US life and annuity provider, with attention on how interest rate...

Prudential Financial recently reported a strong third quarter of 2025, with adjusted earnings per share beating forecasts and assets under management rising 3.5% year over year to about US$1.60 trillion, and analysts are now expecting earnings per share growth for the fourth quarter of 2025 compared with the prior year. This combination of recent outperformance across all business divisions and Prudential’s reputation as a steady dividend payer is drawing fresh attention from investors...

Park National Corporation announced that long-serving director and former CEO C. Daniel DeLawder, after a 55-year career, will retire and not stand for re-election at the 2026 Annual Meeting of Shareholders, concluding his roles on the boards of both Park National Corporation and Park National Bank as well as key committee chair positions. His retirement marks the end of an era of unusually long leadership continuity, potentially prompting investors and stakeholders to reassess how future...

InMode (INMD) has drawn fresh attention after issuing earnings guidance, with the company projecting fourth quarter 2025 revenue of about US$103.6 million to US$103.8 million and detailed ranges for 2025 and 2026. See our latest analysis for InMode. The earnings guidance has arrived after a mixed period for the stock, with a 1-day share price return of 1.26%, a 1-year total shareholder return decline of 9.18%, and a 3-year total shareholder return decline of 55.84%, indicating fading momentum...

Aehr Test Systems (AEHR) has just posted Q2 2026 results with revenue of US$9.9 million and a basic EPS loss of US$0.11, while trailing twelve month figures show revenue of US$53.2 million and a basic EPS loss of US$0.30. Over recent quarters, the company has seen revenue move from US$13.5 million in Q2 2025 to US$18.3 million in Q3 2025, then to US$14.1 million in Q4 2025 and US$11.0 million in Q1 2026, with EPS shifting from a profit of US$0.02 in Q1 2025 to losses across subsequent...

Oddity Tech (ODD) has been drawing attention after recent share price moves, with the stock down over the past week, month, and past 3 months. That pullback is prompting closer scrutiny of its fundamentals. See our latest analysis for Oddity Tech. The recent weakness, including a 1 day share price return decline of 8.02% and a 3 month share price return decline of 29.69%, points to fading momentum. The 1 year total shareholder return decline of 19.85% suggests sentiment has cooled over a...

What recent returns say about Verisk Analytics (VRSK) With no single headline event driving attention, Verisk Analytics (VRSK) has still drawn interest as investors review its recent share performance, revenue and earnings profile, and how that aligns with expectations. See our latest analysis for Verisk Analytics. At a share price of $224.87, Verisk’s recent 4.85% 1 month share price return sits against a 7.48% 3 month share price decline, while the 3 year total shareholder return of 24.58%...

ARGOS launch puts private label in focus for AAP shareholders Advance Auto Parts (AAP) has introduced ARGOS, a new owned oil and fluids brand built around customer feedback and affordability. For shareholders, the move raises fresh questions about margins, brand mix and long term product strategy. See our latest analysis for Advance Auto Parts. ARGOS arrives at a time when the share price has shown short term strength, with a 7 day share price return of 12.73% and a year to date share price...

Sanmina (SANM) has come under closer scrutiny after reports of annual sales and earnings declines over the past two years. These developments have been linked to competitive supply chain pressures and higher production costs, which are weighing on already low gross margins. See our latest analysis for Sanmina. At a share price of US$153.41, Sanmina has seen a 1 day share price return of 2.89%, a 30 day share price return decline of 9.33%, and a 1 year total shareholder return of 98.23%,...

In recent weeks, LP Building Solutions’ parent Louisiana-Pacific has attracted attention as analysts reaffirmed positive views on the company and insiders, including at least one director, increased their share purchases despite ongoing housing market headwinds. At the same time, leadership changes in human resources and plans to report full-year 2025 results in February 2026 highlight a company tightening internal alignment while external sentiment turns more constructive. Next, we’ll...

In early January 2026, ServiceNow announced that former Microsoft Chief Legal Officer Hossein Nowbar has joined as President and Chief Legal Officer, while long-time CLO Russ Elmer moved into a Special Counsel role to support continuity across global legal, compliance, governance, and risk functions. This leadership shift brings deep experience in AI regulation, data privacy, intellectual property, and geopolitical issues into ServiceNow just as it pushes further into AI-native workflows and...

One Stop Systems (OSS) has drawn fresh investor attention after securing an approximately US$1.2 million pre production order from a new U.S. defense prime contractor to equip Army combat vehicles with ruggedized compute and visualization systems. See our latest analysis for One Stop Systems. That new U.S. Army order comes on the heels of OSS closing the US$22.4 million sale of its Bressner Technology subsidiary and refocusing on higher margin defense and edge compute work, with the share...

Earlier this week, President Donald Trump said he had directed his representatives, including Fannie Mae and Freddie Mac, to buy US$200 billion of mortgage bonds in an effort to lower mortgage rates and monthly housing payments. The move signals a push for greater government influence over the housing finance system, potentially expanding Fannie Mae’s role in supporting affordable homeownership through larger mortgage-backed securities holdings. We’ll now examine how this proposed US$200...

In early January 2026, KeifeRx announced a research collaboration and option agreement with Amneal Pharmaceuticals to support pre-IND development of KFRX06, a brain-penetrant LRRK2 inhibitor candidate for Parkinson’s disease. This agreement adds an early-stage neuroscience asset to Amneal’s pipeline and leverages its Parkinson’s development and manufacturing capabilities in a specialized genetic target area. We’ll now examine how adding an LRRK2-targeted Parkinson’s candidate through KeifeRx...

Bunge Global (BG) has been drawing investor attention after a recent move in its share price. The stock last closed at $99.99 and has shown positive returns over the past month and the past 3 months. See our latest analysis for Bunge Global. The recent 2.54% 1 day and 9.28% 30 day share price returns, alongside a 23.80% 90 day share price return, point to building momentum, supported by a 27.41% 1 year total shareholder return and stronger multi year outcomes. If Bunge Global's recent move...

If you are wondering whether AtaiBeckley is still good value after its recent run, this guide walks through the numbers so you can judge the price tag with more confidence. The stock last closed at US$3.75, with a 1 year return of 150.0% despite a 3.1% decline over the past week and a 13.4% decline over the past month. Recent share price moves have come alongside increased attention on AtaiBeckley within the pharmaceuticals and biotech space, with investors reacting to company specific...

EACO (EACO) has kicked off Q1 2026 with total revenue of US$111.0 million and basic EPS of US$1.91, alongside net income of US$9.3 million, setting a clear marker for how the year is starting. Over the past few quarters the company has seen revenue shift from US$93.9 million in Q1 2025 to US$110.0 million in Q3 2025 and US$122.5 million in Q4 2025, while basic EPS moved from US$1.41 to US$1.95 and then US$1.87 over the same period. This gives investors a clearer view of how the top and bottom...

Why Weyerhaeuser Is Back on Investors’ Radar Weyerhaeuser (WY) is catching attention after reporting 2024 net sales of US$7.1b and net income of US$331.0m, putting fresh numbers behind this timberland focused real estate investment trust. With a value score of 1 and recent returns ranging from an 8.1% move over the past week to an 11.7% gain over the past month, investors are reassessing how the current share price of US$25.72 reflects these fundamentals. See our latest analysis for...

If you are wondering whether Alnylam Pharmaceuticals' current share price still makes sense after its strong run, this article will walk through what the numbers are actually saying about value. The stock trades at US$398.29 after a 0.5% decline over the last week and 1.5% decline over the last month, set against a much stronger 67.4% return over the past year and 139.4% over five years. Recent attention on Alnylam has centred on its pipeline of RNA interference therapies and the broader...

Recent analysis of the global agricultural lime market, released before 9 January 2026, projects the sector could reach about US$3 billion by 2033, with players such as United States Lime & Minerals expected to respond through capacity expansion and product innovation to serve rising demand. An interesting angle is how growing awareness of soil acidity and sustainable farming practices is turning a traditionally niche input like agricultural lime into a more critical component of long-term...